Advertisement

Aeglea BioTherapeutics, Inc. AGLE

Set alert

Price alert · AGLE

All alert types
12.01 0.00 0.00%

At close · Nov 27

10.69 Day range 12.34

52-week range unavailable

Open
10.87
Prev close
12.01
Mkt cap
48.63M
Vol
43.24K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
10.69
High
12.34
Forward P/E
-6.53
Beta
2.57
Short ratio
3.68
Inst. own
0.00%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2023
50-d avg
12.64
200-d avg
9.84
1y target
17.50

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for AGLE has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue → Gross Profit: $688.00KGross Profit → Expenses: $688.00KExpenses → Selling, General & Admin: $12.06MExpenses → Research & Development: $17.39MExpenses → Other Operating Expenses: $130.49MExpenses → Other Expenses: $57.83MExpenses → Income Tax: $7.00KNet Loss → Expenses: $217.08MGross Profit$688.00KNet Loss$217.08MExpenses$217.77MSelling, General & Admin$12.06MResearch & Development$17.39MOther Operating Expenses$130.49MOther Expenses$57.83MIncome Tax$7.00KRevenue$688.00K

Period ending Jun 30, 2023 · select a line to chart its history

Income statement

AGLE quarterly income statement
688.00K
688.00K
688.00K
159.93M
17.39M
12.06M
-159.25M
7.00K
-217.08M
-217.08M
-217.08M
-217.08M
-2.27
-2.27
-2.27
-217.07M
-217.07M
95.57M
95.57M

Balance sheet

AGLE quarterly balance sheet
236.68M
236.68M
1.65M
239.89M
2.32M
243.53M
4.33M
4.33M
232.23M
253.57M
-661.13M
11.00K
-207.37M
-207.37M
3.64M
4.33M
3.27M
21.34M
23.66M

Cash flow

AGLE quarterly cash flow
416.00K
209.99M
200.12M
475.00K
3.04M
-8.00K
6.76M
3.25M
-16.64M
13.00K
1.91M
Advertisement